secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2022-03-04T23:59:59+00:00
Accession:  0001104659-22-030657
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Subsidiary President Andrew Gesek resigns; Petros to integrate his role
-----------------------------------------------------------------------

- Andrew Gesek resigned as President of Timm Medical Technologies effective Feb 28, 2022; no disagreement cited.
- Company will not hire a replacement; plans to streamline and integrate operations under current leadership.
- Gesek receives $75,000 cash severance (3 months base salary) paid pro rata over three months.
- Severance includes 24-month non-compete, non-solicitation, and non-disparagement covenants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465922030657/0001104659-22-030657-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465922030657/tm228212d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-030657

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer